American Vanguard Corp Stock Price, News & Analysis

American Vanguard (NYSE:AVD) reported its Q2 2025 financial results, showing significant operational improvements. The company achieved net sales of $129 million, a slight increase from $128 million in Q2 2024, while Adjusted EBITDA surged 80% to $11 million from $6 million year-over-year.

Key highlights include improved gross profit margin of 31% (up from 29%), reduced debt of $189 million (down $22 million YoY), and decreased inventory levels of $191 million (down $53 million YoY). The company reported GAAP EPS of $(0.03) compared to $(0.42) in Q2 2024.

Management reiterated its full-year 2025 guidance, targeting revenue of $535-545 million and adjusted EBITDA of $40-44 million. The company noted early signs of agricultural economy recovery and subsiding customer destocking.

American Vanguard (NYSE:AVD) has scheduled its second quarter 2025 financial results announcement for Thursday, July 31, 2025, after market close. The company will host a conference call to discuss its operating performance and financial results at 5:00 p.m. ET / 2:00 p.m. PT on the same day.

Investors can access the live webcast through the company's website investor section or via a direct webcast link. For those unable to attend the live event, an archived version will be available on American Vanguard's investor relations website.

American Vanguard (NYSE:AVD) announced the results of its 2025 Annual Meeting of Stockholders held on July 2, 2025. Shareholders approved all three initiatives on the ballot with overwhelming support.

The meeting resulted in the election of nine directors: Marisol Angelini, Scott Baskin, Mark Bassett, Patrick Gottschalk, Emer Gunter, Douglas Kaye, Steven Macicek, Keith Rosenbloom, and Carmen Tiu. Additionally, stockholders ratified Deloitte Touche, LLP as the company's independent auditor for 2025 and provided advisory approval for executive compensation policies.

American Vanguard (NYSE: AVD) reported challenging Q1 2025 results amid continued weakness in the global agricultural sector. Net sales declined to $115.8M from $135.1M in Q1 2024, with Adjusted EBITDA falling to $3.0M from $15.5M, and EPS dropping to $(0.30) from $0.06. The company achieved significant cost reductions, with operating expenses down 14% excluding transformation expenses. Net working capital decreased by $85M year-over-year to $153M, and total debt reduced to $167M from $187M. Management expects improvement in Q2 and a stronger second half of 2025, focusing on their strategy to "SIMPLIFY, PRIORITIZE and DELIVER" while continuing cost reduction initiatives if market conditions don't improve.

American Vanguard (NYSE: AVD) has received a notice from the New York Stock Exchange regarding non-compliance with Section 802.01E of the NYSE Listed Company Manual due to delayed filing of its 2024 Annual Report (Form 10-K). The company was unable to file within the 15-day extension period under Rule 12b-25, citing the need for additional time, resources, and effort to complete its year-end reporting process.

The company is actively working to complete the necessary documentation and expects to maintain its NYSE listing while finalizing the Form 10-K. Additionally, AVD has secured an amendment to its credit facility with senior lenders, extending the deadline for providing audited financial statements from 90 to 120 days after December 31, 2024.

American Vanguard (NYSE:AVD) has released preliminary Q4 and full-year 2024 results. The company reported Q4 net sales of $169M (vs $172M in Q4 2023) and Adjusted EBITDA of $18M (vs $22M in 2023). For full-year 2024, net sales were approximately $550M ($563M excluding Dacthal recall impact) compared to $579M in 2023, with Adjusted EBITDA of $42M vs $53M.

Key achievements include reducing inventory by $47M and debt by $22M in Q4. The company recorded approximately $118M in non-recurring charges in 2024 as part of management's repositioning efforts. For 2025, AVD projects revenue of $565-585M and Adjusted EBITDA of $45-52M, with expected capex of $10M.

CEO Douglas Kaye aims to double the current 7.5% EBITDA margin over the next 3-4 years, focusing on simplifying operations and delivering profitable growth.

American Vanguard (NYSE: AVD) has scheduled its fourth quarter 2024 financial results announcement for March 14, 2025, before market opening. The company will host a conference call and webcast at 9:00 a.m. ET / 6:00 a.m. PT on the same day to discuss operating performance and financial results. Investors can access the live webcast through the company's website News and Media section or via the provided webcast link. An archived version of the conference call will be available on the company's investor relations webpage for those unable to attend the live event.

American Vanguard's crop business unit, AMVAC, has entered into a regional distribution agreement with DPH Biologicals, expanding its GreenSolutions portfolio and increasing biological products availability across the U.S. Under the long-term agreement, AMVAC will distribute DPH Bio's key products, including TerraTrove SP-1 Classic, TerraTrove AmplAphex biofertilizers, and BellaTrove Companion Maxx, an EPA-approved biocontrol product.

The partnership allows DPH Bio to strengthen its U.S. market access through AMVAC's commercial and operational teams, initially focusing on specialty crop markets. AMVAC will service DPH Bio's existing customers in the Western and Southern regions, providing enhanced commercial and technical support. The collaboration combines DPH Bio's products with AMVAC's GreenSolutions portfolio, creating an industry-leading offering for growers, distributors, and retail partners.

American Vanguard (NYSE:AVD) announced that its new CEO, Douglas 'Dak' Kaye, III, will participate in an investor forum hosted by Lake Street Capital on January 16, 2025 at 11 a.m. Eastern Time. This will mark Kaye's first presentation to the financial community as AVD's CEO. Kaye brings over 20 years of executive leadership experience, having previously served as North American President of Albaugh, , a global developer, manufacturer, and marketer of crop protection products.